Karoon’s balance sheet remains sound following the Who Dat acquisition. From a net cash position of USD 152 million or just over AUD 0.40 per share as of the end of September 2023, the balance sheet ...
We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...
With Q4 2024 earnings reports for the gig economy approaching, analysts at Moffett Nathanson highlighted six key themes that investors will be watching closely. 1) In US rideshare, the industry saw a ...